Screening for large mutations of the NF2 gene

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Neurofibromatosis 2 (NF2) is a genetic disorder resulting from NF2 gene inactivation.
• NF2 is characterized by tumors, including bilateral vestibular schwannomas and spinal tumors.
• Previous studies identified intragenic NF2 mutations in a significant portion of NF2 patients.

Purpose of the Study:

• To investigate large genomic alterations in the NF2 gene in patients with NF2.
• To enhance the mutation detection rate for NF2 by employing comprehensive screening techniques.
• To characterize the spectrum of mutations, including deletions, duplications, and insertions, in the NF2 gene.

Main Methods:

• Exon-scanning methods were used to detect intragenic NF2 mutations.
• Multiplex ligation-dependent probe amplification (MLPA) was employed to identify large genomic alterations (deletions, duplications).
• mRNA transcript analysis was performed to confirm detected alterations and identify insertions.

Main Results:

• Large alterations (deletions, duplications, insertions) in the NF2 gene were identified in 21 out of 188 patients (11%).
• These large alterations accounted for 27% of cases where small intragenic mutations were not initially detected.
• The combined screening approach achieved a 100% mutation-detection rate for inherited NF2 cases.

Conclusions:

• Comprehensive screening, including MLPA and transcript analysis, is crucial for detecting diverse NF2 gene alterations.
• Identification of large genomic rearrangements significantly improves the diagnostic yield for Neurofibromatosis 2.
• Understanding the full spectrum of NF2 mutations aids in genetic counseling and potential therapeutic strategies.